BRAPACTO
LIVE

Serial Number

79268436

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 3, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BRAPACTO Trademark

Serial Number: 79268436 • Registration: 5987047

BRAPACTO is a trademark filed by Novartis AG on August 3, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

August 3, 2019

Registration Date

February 18, 2020

Published for Opposition

December 3, 2019

Cancellation Date

September 18, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 9, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Apr 9, 2026 DETH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 18, 2025 REM3
NOTIFICATION PROCESSED BY IB
May 29, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Mar 31, 2020 FICS
FINAL DISPOSITION PROCESSED
Mar 31, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Mar 19, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2019 CNSA
ASSIGNED TO EXAMINER
Oct 25, 2019 DOCK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 16, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 16, 2019 REAP
APPLICATION FILING RECEIPT MAILED
Oct 8, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 4, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 27, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Sep 26, 2019 SDRC